Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Icecure Medical Ltd Ord (ICCM)

Icecure Medical Ltd Ord (ICCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Icecure Medical Ltd Ord 7 HA ESHEL STREET PO BOX 3163 CAESAREA L3 3079504 ISR

https://icecure-medical.com P: 972-4623-0333 F: 972-462-3022

Description:

IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel.

Key Statistics

Overview:

Market Capitalization, $K 34,053
Enterprise Value, $K 23,523
Shares Outstanding, K 45,623
Annual Sales, $ 3,230 K
Annual Net Income, $ -14,650 K
Last Quarter Sales, $ 740 K
Last Quarter Net Income, $ -3,610 K
EBIT, $ -3,650 K
EBITDA, $ -3,330 K
60-Month Beta 0.57
% of Insider Shareholders 2.44%
% of Institutional Shareholders 0.62%
Float, K 44,510
% Float 97.56%
Short Volume Ratio 0.58

Growth:

1-Year Return -37.28%
3-Year Return -92.82%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 05/28/24
Next Earnings Date 08/12/24
Earnings Per Share ttm -0.33
EPS Growth vs. Prev Qtr -14.29%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 08/09/21

ICCM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -101.66%
Return-on-Assets % -77.73%
Profit Margin % -453.56%
Debt/Equity 0.00
Price/Sales 10.60
Price/Cash Flow N/A
Price/Book 2.94
Book Value/Share 0.26
Interest Coverage -0.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar